Home › Companies › Collegium Pharmaceutical, Inc. › 2024-2025

Collegium Pharmaceutical, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and Collegium Pharmaceutical, Inc.’s Form 8-K, filed 2025-05-19 (Item 5.07 on EDGAR). Page generated 04 October 2026.

25Reported items
283Asset managers
3,871Fund votes
2025-05-15Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Collegium Pharmaceutical, Inc. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by Collegium Pharmaceutical, Inc.

These tallies are Collegium Pharmaceutical, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-19 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Collegium Pharmaceutical, Inc. — official shareholder meeting results, meeting held 2025-05-15
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Rita Balice-Gordon	24,842,387	251,845	2,550,989	--	1,449,301	Majority: yes
Elect Director: Garen Bohlin	24,980,953	127,522	2,536,746	--	1,449,301	Majority: yes
Elect Director: John Fallon	24,314,536	793,400	2,537,285	--	1,449,301	Majority: yes
Elect Director: John Freund	24,494,346	614,373	2,536,502	--	1,449,301	Majority: yes
Elect Director: Vikram Karnani	25,001,176	107,410	2,536,635	--	1,449,301	Majority: yes
Elect Director: Nancy Lurker	25,089,514	18,982	2,536,725	--	1,449,301	Majority: yes
Elect Director: Carlos Paya	25,074,339	21,938	2,548,944	--	1,449,301	Majority: yes
Elect Director: Gino Santini	24,829,920	278,655	2,536,646	--	1,449,301	Majority: yes
Proposal 2: Approval of, on an advisory basis, the compensation of the Company's named executive officers.	22,867,414	2,233,541	2,544,266	--	1,449,301	Passed
Proposal 4: Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.	28,706,712	141,452	246,358	--	0	Passed
Proposal 5: Approval of the Collegium Pharmaceutical, Inc	20,255,783	7,143,482	245,956	--	1,449,301	Passed

Source: Collegium Pharmaceutical, Inc., Form 8-K, filed with the SEC on 2025-05-19 — read the filing on EDGAR.

How asset managers voted at the Collegium Pharmaceutical, Inc. 2024-2025 meeting

Each item below shows how the 283 asset managers that disclosed a Collegium Pharmaceutical, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Collegium Pharmaceutical, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval of, on an advisory basis, the compensation of the Company's named executive officers

SECTION 14A SAY-ON-PAY VOTESCompany result: Passed

Combines 10 wordings of this item as funds reported it.

91% Passed · of votes cast

FOR 91%9%

FOR: 22,867,414AGAINST: 2,233,541

Collegium Pharmaceutical, Inc.’s own tally for this item (“Proposal 2: Approval of, on an advisory basis, the compensation of the Company's named executive officers.”): 22,867,414 for, 2,233,541 against — passed, per its Form 8-K filed 2025-05-19 (Item 5.07). Of all 32,131,798 outstanding shares: 71% for, 7% against (78% of the company cast a for/against vote).

The 281 asset managers below cast 90% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 83%9%8%

FOR: 83.2%AGAINST: 9.3%ABSTAIN: 7.5%NOT VOTED: 0.0%

Largest asset managers voting on “Approval of, on an advisory basis, the compensation of the Company's named executive officers” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Abstain	Vote
BlackRock	4,045,910	0	0	For
MUTUAL FUND SERIES TRUST	2,629,593	0	0	For
Rubric Capital Management LP	0	0	2,290,905	Abstain
Vanguard	2,281,372	1,893	4	For
Invesco	0	2,111,873	0	Against
State Street	1,463,912	675	0	For
FULLER & THALER ASSET MANAGEMENT, INC.	1,358,856	0	0	For
Capitol Series Trust	1,305,864	0	0	For
PRINCIPAL GLOBAL INVESTORS	1,014,939	0	0	For
Dimensional	832,046	0	0	For
Principal	810,996	0	0	For
Fidelity	764,524	0	0	For
GEODE CAPITAL MANAGEMENT, LLC	760,493	0	0	For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	713,859	0	0	For
Renaissance	697,138	0	0	For
Charles Schwab	672,587	0	0	For
SEI	637,829	0	0	For
MFS	628,245	0	0	For
EMERALD MUTUAL FUND ADVISERS TRUST	573,376	0	0	For
Victory Capital	549,830	0	0	For
Pacer Funds Trust	416,944	0	0	For
Janus Henderson	388,575	0	0	For
EMERALD ADVISERS, LLC	334,689	0	0	For
Royce	298,308	0	0	For
FINANCIAL INVESTORS TRUST	284,631	0	0	For

Showing the 25 largest of 281 asset managers. See all 281 in the interactive database.

2. TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS

SECTION 14A SAY-ON-PAY VOTES

Combines 7 wordings of this item as funds reported it.

100% fund support · no official result

ONE YEAR 63%1 YEAR 34%

The 266 asset managers below cast 100% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR: 0.2%ABSTAIN: 0.8%ONE YEAR: 62.5%1 YEAR: 33.8%THREE YEARS: 2.6%3 YEARS: 0.2%NOT VOTED: 0.0%1-YEAR: 0.0%3 YEAR: 0.0%2 YEAR: 0.0%

Largest asset managers voting on “TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION O” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
BlackRock	0	0	0	0	1 Year
MUTUAL FUND SERIES TRUST	0	0	0	0	One Year
Rubric Capital Management LP	0	0	0	0	1 Year
Vanguard	0	0	0	0	One Year
Invesco	0	0	0	0	One Year
State Street	0	0	0	0	One Year
FULLER & THALER ASSET MANAGEMENT, INC.	0	0	0	0	One Year
PRINCIPAL GLOBAL INVESTORS	0	0	0	0	One Year
Dimensional	0	0	0	0	Three Years
Principal	0	0	0	0	One Year
Fidelity	0	0	0	0	One Year
GEODE CAPITAL MANAGEMENT, LLC	0	0	0	0	One Year
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	0	0	0	0	One Year
Renaissance	0	0	0	0	One Year
Charles Schwab	0	0	0	0	1 Year
SEI	0	0	0	0	1 Year
MFS	0	0	0	0	One Year
EMERALD MUTUAL FUND ADVISERS TRUST	0	0	0	0	1 Year
Victory Capital	0	0	0	0	One Year
Pacer Funds Trust	0	0	0	0	1 Year
Janus Henderson	0	0	0	0	One Year
EMERALD ADVISERS, LLC	0	0	0	0	1 Year
Royce	0	0	0	0	One Year
FINANCIAL INVESTORS TRUST	0	0	0	0	1 Year
Northern Trust	0	0	0	0	1 Year

Showing the 25 largest of 266 asset managers. See all 266 in the interactive database.

3. Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025

AUDIT-RELATEDCompany result: Passed

Combines 3 wordings of this item as funds reported it.

99.5% Passed · of votes cast

FOR 99.5%

FOR: 28,706,712AGAINST: 141,452

Collegium Pharmaceutical, Inc.’s own tally for this item (“Proposal 4: Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”): 28,706,712 for, 141,452 against — passed, per its Form 8-K filed 2025-05-19 (Item 5.07). Of all 32,131,798 outstanding shares: 89% for, 0.5% against (90% of the company cast a for/against vote).

The 92 asset managers below cast 99.7% of the shares they voted on this item FOR (17,195,125 for, 36,365 against).

FOR 99.7%

FOR: 17,195,125 (99.7%)AGAINST: 36,365 (0.2%)ABSTAIN: 6,909 (0.0%)

Largest asset managers voting on “Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accoun” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Vote
BlackRock	2,870,191	0	For
MUTUAL FUND SERIES TRUST	2,629,593	0	For
Vanguard	2,172,898	0	For
Capitol Series Trust	1,305,864	0	For
Invesco	941,338	0	For
Principal	810,996	0	For
Dimensional	750,864	0	For
Fidelity	724,255	0	For
MFS	628,245	0	For
State Street	418,799	17	For
Pacer Funds Trust	416,944	0	For
Charles Schwab	321,019	0	For
SEI	299,236	0	For
Royce	295,681	0	For
FINANCIAL INVESTORS TRUST	284,631	0	For
THIRD AVENUE TRUST	203,008	0	For
Victory Capital	195,111	0	For
World Funds Trust	165,208	0	For
Pacific Life	95,765	0	For
MassMutual	92,959	0	For
Equitable	92,849	0	For
American Century	89,533	0	For
TIAA	87,848	0	For
RBB FUND, INC.	79,591	0	For
AMERICAN BEACON FUNDS	75,980	0	For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

4. To approve the Collegium Pharmaceutical, Inc. 2025 Equity Incentive Plan

COMPENSATIONCompany result: Passed

74% Passed · of votes cast

FOR 74%AGAINST 26%

FOR: 20,255,783AGAINST: 7,143,482

Collegium Pharmaceutical, Inc.’s own tally for this item (“Proposal 5: Approval of the Collegium Pharmaceutical, Inc”): 20,255,783 for, 7,143,482 against — passed, per its Form 8-K filed 2025-05-19 (Item 5.07). Of all 32,131,798 outstanding shares: 63% for, 22% against (85% of the company cast a for/against vote).

The 92 asset managers below cast 78% of the shares they voted on this item FOR (13,420,611 for, 3,771,816 against).

FOR 77%AGAINST 22%

FOR: 13,420,611 (77.0%)AGAINST: 3,771,816 (21.6%)ABSTAIN: 236,655 (1.4%)

Largest asset managers voting on “To approve the Collegium Pharmaceutical, Inc. 2025 Equity Incentive Plan” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Abstain	Vote
BlackRock	2,870,191	0	0	For
MUTUAL FUND SERIES TRUST	2,629,593	0	0	For
Vanguard	2,172,886	13	0	For
Capitol Series Trust	0	1,305,864	0	Against
Invesco	941,338	0	0	For
Principal	810,996	0	0	For
Dimensional	0	750,864	0	Against
Fidelity	724,255	0	0	For
MFS	628,245	0	0	For
State Street	408,733	10,083	0	For
Pacer Funds Trust	0	416,944	0	Against
Charles Schwab	321,019	0	0	For
SEI	299,236	0	0	For
Royce	0	295,681	0	Against
FINANCIAL INVESTORS TRUST	284,631	0	0	For
Quantedge Capital Pte Ltd	0	0	234,855	Abstain
THIRD AVENUE TRUST	203,008	0	0	For
Victory Capital	0	195,111	0	Against
World Funds Trust	0	165,208	0	Against
Pacific Life	95,765	0	0	For
MassMutual	92,959	0	0	For
Equitable	92,849	0	0	For
American Century	0	89,533	0	Against
TIAA	87,848	0	0	For
RBB FUND, INC.	79,591	0	0	For

Showing the 25 largest of 92 asset managers. See all 92 in the interactive database.

5. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Carlos Paya

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 59 asset managers below cast 100% of the shares they voted on this item FOR (12,230,000 for, 0 against).

FOR: 12,230,000 (100.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	2,629,593	For
Vanguard	2,168,915	For
Capitol Series Trust	1,305,864	For
Invesco	941,338	For
Principal	810,996	For
Dimensional	750,864	For
Fidelity	724,255	For
MFS	628,245	For
State Street	418,816	For
Royce	295,681	For
Victory Capital	195,111	For
Pacific Life	95,765	For
MassMutual	92,959	For
Equitable	92,849	For
American Century	89,533	For
TIAA	87,848	For
AMERICAN BEACON FUNDS	75,980	For
Columbia Threadneedle	67,968	For
Janus Detroit Street Trust	67,309	For
EXCHANGE TRADED CONCEPTS TRUST	62,304	For
Goldman Sachs	51,346	For
WisdomTree	49,874	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	45,300	For
Lincoln Financial	45,240	For
First Trust	42,855	For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

6. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Garen Bohlin

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 59 asset managers below cast 100% of the shares they voted on this item FOR (12,230,000 for, 0 against).

FOR: 12,230,000 (100.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	2,629,593	For
Vanguard	2,168,915	For
Capitol Series Trust	1,305,864	For
Invesco	941,338	For
Principal	810,996	For
Dimensional	750,864	For
Fidelity	724,255	For
MFS	628,245	For
State Street	418,816	For
Royce	295,681	For
Victory Capital	195,111	For
Pacific Life	95,765	For
MassMutual	92,959	For
Equitable	92,849	For
American Century	89,533	For
TIAA	87,848	For
AMERICAN BEACON FUNDS	75,980	For
Columbia Threadneedle	67,968	For
Janus Detroit Street Trust	67,309	For
EXCHANGE TRADED CONCEPTS TRUST	62,304	For
Goldman Sachs	51,346	For
WisdomTree	49,874	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	45,300	For
Lincoln Financial	45,240	For
First Trust	42,855	For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

7. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Gino Santini

DIRECTOR ELECTIONS

99.9% fund support · no official result

FOR 99.9%

The 59 asset managers below cast 99.9% of the shares they voted on this item FOR (12,226,564 for, 3,436 against).

FOR: 12,226,564 (100.0%)AGAINST: 3,436 (0.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	2,629,593	0	For
Vanguard	2,168,915	0	For
Capitol Series Trust	1,305,864	0	For
Invesco	941,338	0	For
Principal	810,996	0	For
Dimensional	750,864	0	For
Fidelity	724,255	0	For
MFS	628,245	0	For
State Street	418,799	17	For
Royce	295,681	0	For
Victory Capital	195,111	0	For
Pacific Life	95,765	0	For
MassMutual	92,959	0	For
Equitable	92,849	0	For
American Century	89,533	0	For
TIAA	87,848	0	For
AMERICAN BEACON FUNDS	75,980	0	For
Columbia Threadneedle	67,968	0	For
Janus Detroit Street Trust	67,309	0	For
EXCHANGE TRADED CONCEPTS TRUST	62,304	0	For
Goldman Sachs	51,346	0	For
WisdomTree	49,874	0	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	45,300	0	For
Lincoln Financial	45,240	0	For
First Trust	42,855	0	For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

8. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: John Fallon, M.D.

DIRECTOR ELECTIONS

99.9% fund support · no official result

FOR 99.9%

The 59 asset managers below cast 99.9% of the shares they voted on this item FOR (12,226,581 for, 3,419 against).

FOR: 12,226,581 (100.0%)AGAINST: 3,419 (0.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	2,629,593	For
Vanguard	2,168,915	For
Capitol Series Trust	1,305,864	For
Invesco	941,338	For
Principal	810,996	For
Dimensional	750,864	For
Fidelity	724,255	For
MFS	628,245	For
State Street	418,816	For
Royce	295,681	For
Victory Capital	195,111	For
Pacific Life	95,765	For
MassMutual	92,959	For
Equitable	92,849	For
American Century	89,533	For
TIAA	87,848	For
AMERICAN BEACON FUNDS	75,980	For
Columbia Threadneedle	67,968	For
Janus Detroit Street Trust	67,309	For
EXCHANGE TRADED CONCEPTS TRUST	62,304	For
Goldman Sachs	51,346	For
WisdomTree	49,874	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	45,300	For
Lincoln Financial	45,240	For
First Trust	42,855	For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

9. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: John Freund, M.D.

DIRECTOR ELECTIONS

99.9% fund support · no official result

FOR 99.9%

The 59 asset managers below cast 99.9% of the shares they voted on this item FOR (12,229,983 for, 17 against).

FOR: 12,229,983 (100.0%)AGAINST: 17 (0.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	2,629,593	0	For
Vanguard	2,168,915	0	For
Capitol Series Trust	1,305,864	0	For
Invesco	941,338	0	For
Principal	810,996	0	For
Dimensional	750,864	0	For
Fidelity	724,255	0	For
MFS	628,245	0	For
State Street	418,799	17	For
Royce	295,681	0	For
Victory Capital	195,111	0	For
Pacific Life	95,765	0	For
MassMutual	92,959	0	For
Equitable	92,849	0	For
American Century	89,533	0	For
TIAA	87,848	0	For
AMERICAN BEACON FUNDS	75,980	0	For
Columbia Threadneedle	67,968	0	For
Janus Detroit Street Trust	67,309	0	For
EXCHANGE TRADED CONCEPTS TRUST	62,304	0	For
Goldman Sachs	51,346	0	For
WisdomTree	49,874	0	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	45,300	0	For
Lincoln Financial	45,240	0	For
First Trust	42,855	0	For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

10. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Nancy Lurker

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 59 asset managers below cast 100% of the shares they voted on this item FOR (12,230,000 for, 0 against).

FOR: 12,230,000 (100.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	2,629,593	For
Vanguard	2,168,915	For
Capitol Series Trust	1,305,864	For
Invesco	941,338	For
Principal	810,996	For
Dimensional	750,864	For
Fidelity	724,255	For
MFS	628,245	For
State Street	418,816	For
Royce	295,681	For
Victory Capital	195,111	For
Pacific Life	95,765	For
MassMutual	92,959	For
Equitable	92,849	For
American Century	89,533	For
TIAA	87,848	For
AMERICAN BEACON FUNDS	75,980	For
Columbia Threadneedle	67,968	For
Janus Detroit Street Trust	67,309	For
EXCHANGE TRADED CONCEPTS TRUST	62,304	For
Goldman Sachs	51,346	For
WisdomTree	49,874	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	45,300	For
Lincoln Financial	45,240	For
First Trust	42,855	For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

11. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Rita Balice-Gordon, Ph.D.

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 59 asset managers below cast 100% of the shares they voted on this item FOR (12,230,000 for, 0 against).

FOR: 12,230,000 (100.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Vote
MUTUAL FUND SERIES TRUST	2,629,593	For
Vanguard	2,168,915	For
Capitol Series Trust	1,305,864	For
Invesco	941,338	For
Principal	810,996	For
Dimensional	750,864	For
Fidelity	724,255	For
MFS	628,245	For
State Street	418,816	For
Royce	295,681	For
Victory Capital	195,111	For
Pacific Life	95,765	For
MassMutual	92,959	For
Equitable	92,849	For
American Century	89,533	For
TIAA	87,848	For
AMERICAN BEACON FUNDS	75,980	For
Columbia Threadneedle	67,968	For
Janus Detroit Street Trust	67,309	For
EXCHANGE TRADED CONCEPTS TRUST	62,304	For
Goldman Sachs	51,346	For
WisdomTree	49,874	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	45,300	For
Lincoln Financial	45,240	For
First Trust	42,855	For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

12. Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini as directors to hold office until the 2026 Annual Meeting: Vikram Karnani

DIRECTOR ELECTIONS

99.9% fund support · no official result

FOR 99.9%

The 59 asset managers below cast 99.9% of the shares they voted on this item FOR (12,229,988 for, 12 against).

FOR: 12,229,988 (100.0%)AGAINST: 12 (0.0%)

Largest asset managers voting on “Election of Rita Balice-Gordon, Ph.D., Garen Bohlin, John Fallon M.D., John Freund, M.D., Vikram Karnani, Nanc” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Vote
MUTUAL FUND SERIES TRUST	2,629,593	0	For
Vanguard	2,168,915	0	For
Capitol Series Trust	1,305,864	0	For
Invesco	941,338	0	For
Principal	810,996	0	For
Dimensional	750,864	0	For
Fidelity	724,255	0	For
MFS	628,245	0	For
State Street	418,804	12	For
Royce	295,681	0	For
Victory Capital	195,111	0	For
Pacific Life	95,765	0	For
MassMutual	92,959	0	For
Equitable	92,849	0	For
American Century	89,533	0	For
TIAA	87,848	0	For
AMERICAN BEACON FUNDS	75,980	0	For
Columbia Threadneedle	67,968	0	For
Janus Detroit Street Trust	67,309	0	For
EXCHANGE TRADED CONCEPTS TRUST	62,304	0	For
Goldman Sachs	51,346	0	For
WisdomTree	49,874	0	For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	45,300	0	For
Lincoln Financial	45,240	0	For
First Trust	42,855	0	For

Showing the 25 largest of 59 asset managers. See all 59 in the interactive database.

13. Election of Director to hold office until the 2026 Annual Meeting: Carlos Paya

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 25,074,339AGAINST: 21,938

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Carlos Paya”): 25,074,339 for, 21,938 against, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,131,798 outstanding shares: 78% for, 0.1% against (78% of the company cast a for/against vote).

The 38 asset managers below cast 99.9% of the shares they voted on this item FOR (4,986,079 for, 0 against).

FOR 99.8%

FOR: 4,986,079 (99.9%)AGAINST: 0 (0.0%)ABSTAIN: 6,913 (0.1%)

Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: Carlos Paya” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Abstain	Vote
BlackRock	2,870,191	0	For
Pacer Funds Trust	416,944	0	For
Charles Schwab	321,019	0	For
SEI	299,236	0	For
FINANCIAL INVESTORS TRUST	284,631	0	For
THIRD AVENUE TRUST	203,008	0	For
World Funds Trust	165,208	0	For
RBB FUND, INC.	79,591	0	For
Jackson National	64,411	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	For
JPMorgan	40,088	0	For
SEI Exchange Traded Funds	28,217	0	For
Empower	25,384	0	For
Loomis Sayles	25,227	0	For
Harbor ETF Trust	20,568	0	For
Global X	19,026	0	For
ETF Series Solutions	15,925	0	For
Allianz	11,615	0	For
John Hancock	11,474	0	For
Brighthouse	0	6,909	Abstain
Bridge Builder Trust	6,259	0	For
GPS Funds I	4,593	0	For
Vanguard	3,980	4	For
Tidal Trust III	3,295	0	For
Prudential/PGIM	2,919	0	For

Showing the 25 largest of 38 asset managers. See all 38 in the interactive database.

14. Election of Director to hold office until the 2026 Annual Meeting: Garen Bohlin

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%

FOR: 24,980,953AGAINST: 127,522

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Garen Bohlin”): 24,980,953 for, 127,522 against, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,131,798 outstanding shares: 78% for, 0.4% against (78% of the company cast a for/against vote).

The 37 asset managers below cast 99.6% of the shares they voted on this item FOR (4,969,319 for, 16,055 against).

FOR 99.5%

FOR: 4,969,319 (99.5%)AGAINST: 16,055 (0.3%)ABSTAIN: 6,913 (0.1%)

Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: Garen Bohlin” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Abstain	Vote
BlackRock	2,870,191	0	0	For
Pacer Funds Trust	416,944	0	0	For
Charles Schwab	321,019	0	0	For
SEI	299,236	0	0	For
FINANCIAL INVESTORS TRUST	284,631	0	0	For
THIRD AVENUE TRUST	203,008	0	0	For
World Funds Trust	165,208	0	0	For
RBB FUND, INC.	79,591	0	0	For
Jackson National	64,411	0	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	0	For
JPMorgan	40,088	0	0	For
SEI Exchange Traded Funds	28,217	0	0	For
Empower	25,384	0	0	For
Loomis Sayles	25,227	0	0	For
Harbor ETF Trust	20,568	0	0	For
Global X	19,026	0	0	For
ETF Series Solutions	0	15,925	0	Against
Allianz	11,615	0	0	For
John Hancock	11,474	0	0	For
Brighthouse	0	0	6,909	Abstain
Bridge Builder Trust	6,259	0	0	For
GPS Funds I	4,593	0	0	For
Vanguard	3,980	0	4	For
Tidal Trust III	3,295	0	0	For
Prudential/PGIM	2,919	0	0	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

15. Election of Director to hold office until the 2026 Annual Meeting: Gino Santini

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 24,829,920AGAINST: 278,655

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Gino Santini”): 24,829,920 for, 278,655 against, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,131,798 outstanding shares: 77% for, 0.9% against (78% of the company cast a for/against vote).

The 37 asset managers below cast 99.6% of the shares they voted on this item FOR (4,966,495 for, 18,879 against).

FOR 99.4%

FOR: 4,966,495 (99.5%)AGAINST: 18,879 (0.4%)ABSTAIN: 6,913 (0.1%)

Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: Gino Santini” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Abstain	Vote
BlackRock	2,870,191	0	0	For
Pacer Funds Trust	416,944	0	0	For
Charles Schwab	321,019	0	0	For
SEI	299,236	0	0	For
FINANCIAL INVESTORS TRUST	284,631	0	0	For
THIRD AVENUE TRUST	203,008	0	0	For
World Funds Trust	165,208	0	0	For
RBB FUND, INC.	79,591	0	0	For
Jackson National	64,411	0	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	0	For
JPMorgan	40,088	0	0	For
SEI Exchange Traded Funds	28,217	0	0	For
Empower	25,384	0	0	For
Loomis Sayles	25,227	0	0	For
Harbor ETF Trust	20,568	0	0	For
Global X	19,026	0	0	For
ETF Series Solutions	0	15,925	0	Against
Allianz	11,615	0	0	For
John Hancock	11,474	0	0	For
Brighthouse	0	0	6,909	Abstain
Bridge Builder Trust	6,259	0	0	For
GPS Funds I	4,593	0	0	For
Vanguard	3,980	0	4	For
Tidal Trust III	3,295	0	0	For
Prudential/PGIM	2,919	0	0	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

16. Election of Director to hold office until the 2026 Annual Meeting: John Fallon, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%

FOR: 24,314,536AGAINST: 793,400

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: John Fallon”): 24,314,536 for, 793,400 against, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,131,798 outstanding shares: 76% for, 2% against (78% of the company cast a for/against vote).

The 37 asset managers below cast 99.9% of the shares they voted on this item FOR (4,982,549 for, 2,825 against).

FOR 99.8%

FOR: 4,982,549 (99.8%)AGAINST: 2,825 (0.1%)ABSTAIN: 6,913 (0.1%)

Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: John Fallon, M.D.” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Abstain	Vote
BlackRock	2,870,191	0	0	For
Pacer Funds Trust	416,944	0	0	For
Charles Schwab	321,019	0	0	For
SEI	299,236	0	0	For
FINANCIAL INVESTORS TRUST	284,631	0	0	For
THIRD AVENUE TRUST	203,008	0	0	For
World Funds Trust	165,208	0	0	For
RBB FUND, INC.	79,591	0	0	For
Jackson National	64,411	0	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	0	For
JPMorgan	40,088	0	0	For
SEI Exchange Traded Funds	28,217	0	0	For
Empower	25,384	0	0	For
Loomis Sayles	25,227	0	0	For
Harbor ETF Trust	20,568	0	0	For
Global X	19,026	0	0	For
ETF Series Solutions	15,925	0	0	For
Allianz	11,615	0	0	For
John Hancock	11,474	0	0	For
Brighthouse	0	0	6,909	Abstain
Bridge Builder Trust	6,259	0	0	For
GPS Funds I	4,593	0	0	For
Vanguard	3,979	1	4	For
Tidal Trust III	3,295	0	0	For
Prudential/PGIM	2,919	0	0	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

17. Election of Director to hold office until the 2026 Annual Meeting: John Freund, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%

FOR: 24,494,346AGAINST: 614,373

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: John Freund”): 24,494,346 for, 614,373 against, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,131,798 outstanding shares: 76% for, 2% against (78% of the company cast a for/against vote).

The 37 asset managers below cast 99.6% of the shares they voted on this item FOR (4,966,494 for, 18,880 against).

FOR 99.4%

FOR: 4,966,494 (99.5%)AGAINST: 18,880 (0.4%)ABSTAIN: 6,913 (0.1%)

Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: John Freund, M.D.” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Abstain	Vote
BlackRock	2,870,191	0	0	For
Pacer Funds Trust	416,944	0	0	For
Charles Schwab	321,019	0	0	For
SEI	299,236	0	0	For
FINANCIAL INVESTORS TRUST	284,631	0	0	For
THIRD AVENUE TRUST	203,008	0	0	For
World Funds Trust	165,208	0	0	For
RBB FUND, INC.	79,591	0	0	For
Jackson National	64,411	0	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	0	For
JPMorgan	40,088	0	0	For
SEI Exchange Traded Funds	28,217	0	0	For
Empower	25,384	0	0	For
Loomis Sayles	25,227	0	0	For
Harbor ETF Trust	20,568	0	0	For
Global X	19,026	0	0	For
ETF Series Solutions	0	15,925	0	Against
Allianz	11,615	0	0	For
John Hancock	11,474	0	0	For
Brighthouse	0	0	6,909	Abstain
Bridge Builder Trust	6,259	0	0	For
GPS Funds I	4,593	0	0	For
Vanguard	3,979	1	4	For
Tidal Trust III	3,295	0	0	For
Prudential/PGIM	2,919	0	0	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

18. Election of Director to hold office until the 2026 Annual Meeting: Nancy Lurker

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%

FOR: 25,089,514AGAINST: 18,982

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Nancy Lurker”): 25,089,514 for, 18,982 against, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,131,798 outstanding shares: 78% for, 0.1% against (78% of the company cast a for/against vote).

The 37 asset managers below cast 99.9% of the shares they voted on this item FOR (4,985,374 for, 0 against).

FOR 99.8%

FOR: 4,985,374 (99.9%)AGAINST: 0 (0.0%)ABSTAIN: 6,913 (0.1%)

Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: Nancy Lurker” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Abstain	Vote
BlackRock	2,870,191	0	For
Pacer Funds Trust	416,944	0	For
Charles Schwab	321,019	0	For
SEI	299,236	0	For
FINANCIAL INVESTORS TRUST	284,631	0	For
THIRD AVENUE TRUST	203,008	0	For
World Funds Trust	165,208	0	For
RBB FUND, INC.	79,591	0	For
Jackson National	64,411	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	For
JPMorgan	40,088	0	For
SEI Exchange Traded Funds	28,217	0	For
Empower	25,384	0	For
Loomis Sayles	25,227	0	For
Harbor ETF Trust	20,568	0	For
Global X	19,026	0	For
ETF Series Solutions	15,925	0	For
Allianz	11,615	0	For
John Hancock	11,474	0	For
Brighthouse	0	6,909	Abstain
Bridge Builder Trust	6,259	0	For
GPS Funds I	4,593	0	For
Vanguard	3,980	4	For
Tidal Trust III	3,295	0	For
Prudential/PGIM	2,919	0	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

19. Election of Director to hold office until the 2026 Annual Meeting: Rita Balice-Gordon, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%

FOR: 24,842,387AGAINST: 251,845

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Rita Balice-Gordon”): 24,842,387 for, 251,845 against, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,131,798 outstanding shares: 77% for, 0.8% against (78% of the company cast a for/against vote).

The 37 asset managers below cast 99.9% of the shares they voted on this item FOR (4,982,550 for, 2,824 against).

FOR 99.8%

FOR: 4,982,550 (99.8%)AGAINST: 2,824 (0.1%)ABSTAIN: 6,913 (0.1%)

Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: Rita Balice-Gordon, Ph.D.” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Abstain	Vote
BlackRock	2,870,191	0	For
Pacer Funds Trust	416,944	0	For
Charles Schwab	321,019	0	For
SEI	299,236	0	For
FINANCIAL INVESTORS TRUST	284,631	0	For
THIRD AVENUE TRUST	203,008	0	For
World Funds Trust	165,208	0	For
RBB FUND, INC.	79,591	0	For
Jackson National	64,411	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	For
JPMorgan	40,088	0	For
SEI Exchange Traded Funds	28,217	0	For
Empower	25,384	0	For
Loomis Sayles	25,227	0	For
Harbor ETF Trust	20,568	0	For
Global X	19,026	0	For
ETF Series Solutions	15,925	0	For
Allianz	11,615	0	For
John Hancock	11,474	0	For
Brighthouse	0	6,909	Abstain
Bridge Builder Trust	6,259	0	For
GPS Funds I	4,593	0	For
Vanguard	3,980	4	For
Tidal Trust III	3,295	0	For
Prudential/PGIM	2,919	0	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

20. Election of Director to hold office until the 2026 Annual Meeting: Vikram Karnani

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%

FOR: 25,001,176AGAINST: 107,410

Collegium Pharmaceutical, Inc.’s own tally for this item (“Elect Director: Vikram Karnani”): 25,001,176 for, 107,410 against, per its Form 8-K filed 2025-05-19 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 32,131,798 outstanding shares: 78% for, 0.4% against (78% of the company cast a for/against vote).

The 37 asset managers below cast 99.9% of the shares they voted on this item FOR (4,985,374 for, 0 against).

FOR 99.8%

FOR: 4,985,374 (99.9%)AGAINST: 0 (0.0%)ABSTAIN: 6,913 (0.1%)

Largest asset managers voting on “Election of Director to hold office until the 2026 Annual Meeting: Vikram Karnani” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Abstain	Vote
BlackRock	2,870,191	0	For
Pacer Funds Trust	416,944	0	For
Charles Schwab	321,019	0	For
SEI	299,236	0	For
FINANCIAL INVESTORS TRUST	284,631	0	For
THIRD AVENUE TRUST	203,008	0	For
World Funds Trust	165,208	0	For
RBB FUND, INC.	79,591	0	For
Jackson National	64,411	0	For
ADVISORS' INNER CIRCLE FUND	48,200	0	For
JPMorgan	40,088	0	For
SEI Exchange Traded Funds	28,217	0	For
Empower	25,384	0	For
Loomis Sayles	25,227	0	For
Harbor ETF Trust	20,568	0	For
Global X	19,026	0	For
ETF Series Solutions	15,925	0	For
Allianz	11,615	0	For
John Hancock	11,474	0	For
Brighthouse	0	6,909	Abstain
Bridge Builder Trust	6,259	0	For
GPS Funds I	4,593	0	For
Vanguard	3,980	4	For
Tidal Trust III	3,295	0	For
Prudential/PGIM	2,919	0	For

Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.

21. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

— fund support · no official result

1 YEAR 52.1%ONE YEAR 47.9%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

1 YEAR: 102,452 (52.1%)ONE YEAR: 94,231 (47.9%)

Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Uniplan Investment Counsel, Inc.	0	0	0	0	1 Year
JPMorgan	0	0	0	0	One Year
Empower	0	0	0	0	One Year
HC CAPITAL TRUST	0	0	0	0	One Year
CLEARWATER INVESTMENT TRUST	0	0	0	0	One Year

22. Approve Omnibus Stock Plan

COMPENSATION

0% fund support · no official result

AGAINST 100%

The 3 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 28,208 against).

AGAINST: 28,208 (100.0%)

Largest asset managers voting on “Approve Omnibus Stock Plan” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	Against	Vote
Empower	25,384	Against
HC CAPITAL TRUST	1,709	Against
CLEARWATER INVESTMENT TRUST	1,115	Against

23. 14A Executive Compensation Vote Frequency

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 99.8%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (16,112 for, 0 against).

FOR: 16,112 (99.8%)1 YEAR: 30 (0.2%)

Largest asset managers voting on “14A Executive Compensation Vote Frequency” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
James Alpha Funds Trust	16,112	0	0	0	For
Focus Partners Wealth	0	0	0	0	1 Year

24. Amendment to the 2025 Equity Incentive Plan

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR (4,656 for, 0 against).

FOR: 4,656 (100.0%)

Largest asset managers voting on “Amendment to the 2025 Equity Incentive Plan” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	4,625	0	0	0	For
ALGERT GLOBAL LLC	31	0	0	0	For

25. Frequency of Advisory Vote on Executive Compensation

SECTION 14A SAY-ON-PAY VOTES

— fund support · no official result

1 YEAR 99.3%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

1 YEAR: 4,625 (99.3%)ONE YEAR: 31 (0.7%)

Largest asset managers voting on “Frequency of Advisory Vote on Executive Compensation” at Collegium Pharmaceutical, Inc., 2024-2025
Asset manager	For	Against	Abstain	Withheld	Vote
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	0	0	0	0	1 Year
ALGERT GLOBAL LLC	0	0	0	0	One Year

Largest Collegium Pharmaceutical, Inc. shareholders voting in 2024-2025

Ranked by the number of Collegium Pharmaceutical, Inc. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 32,131,798 shares outstanding at the time of that meeting.

Top Collegium Pharmaceutical, Inc. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	BlackRock	12.59%
2	MUTUAL FUND SERIES TRUST	8.18%
3	Rubric Capital Management LP	7.13%
4	Vanguard	7.11%
5	Invesco	6.57%
6	State Street	4.56%
7	FULLER & THALER ASSET MANAGEMENT, INC.	4.23%
8	Capitol Series Trust	4.06%
9	PRINCIPAL GLOBAL INVESTORS	3.16%
10	Dimensional	2.59%

Reported Collegium Pharmaceutical, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Collegium Pharmaceutical, Inc. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
BlackRock	16.97%	13F
BlackRock Institutional Trust Company, N.A.	15.41%	DEF14A
Rubric Capital Management LP	7.31%	DEF14A
Vanguard Group	6.99%	13F
Pacer Advisors, Inc.	6.67%	DEF14A
Pacer US Small Cap Cash Cows ETF	6.66%	13G
JANUS HENDERSON GROUP PLC	5.68%	13G
Invesco	5.08%	13F
Renaissance Technologies	5.03%	13F
Integrated Core Strategies (US) LLC	4.72%	13G

Percentages above are of 32,131,798 shares outstanding, as reported by Collegium Pharmaceutical, Inc. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Collegium Pharmaceutical, Inc.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At Collegium Pharmaceutical, Inc.'s shareholder meeting held 2025-05-15, in the 2024-2025 proxy season, 283 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,871 separate fund positions. Their filings are grouped here into 25 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval of, on an advisory basis, the compensation of the Company's named executive officers — the proposal passed with 91% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Collegium Pharmaceutical, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-19.

Collegium Pharmaceutical, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.